BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 31421262)

  • 1. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
    Liang Y; Zhang H; Song X; Yang Q
    Semin Cancer Biol; 2020 Feb; 60():14-27. PubMed ID: 31421262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular complexity of breast cancer metastases.
    Kimbung S; Loman N; Hedenfalk I
    Semin Cancer Biol; 2015 Dec; 35():85-95. PubMed ID: 26319607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.
    Medeiros B; Allan AL
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-Specificity of Breast Cancer Metastasis.
    Ibragimova MK; Tsyganov MM; Kravtsova EA; Tsydenova IA; Litviakov NV
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer lung metastasis: Molecular biology and therapeutic implications.
    Jin L; Han B; Siegel E; Cui Y; Giuliano A; Cui X
    Cancer Biol Ther; 2018; 19(10):858-868. PubMed ID: 29580128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Immunotherapy in Metastatic Breast Cancer.
    Mansour M; Teo ZL; Luen SJ; Loi S
    Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.
    Borin TF; Angara K; Rashid MH; Achyut BR; Arbab AS
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
    Menyailo ME; Tretyakova MS; Denisov EV
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin receptor in breast cancer: marker for metastatic risk.
    Shemanko CS
    J Mol Endocrinol; 2016 Nov; 57(4):R153-R165. PubMed ID: 27658959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.
    Yousefi M; Nosrati R; Salmaninejad A; Dehghani S; Shahryari A; Saberi A
    Cell Oncol (Dordr); 2018 Apr; 41(2):123-140. PubMed ID: 29568985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.
    Ording AG; Heide-Jørgensen U; Christiansen CF; Nørgaard M; Acquavella J; Sørensen HT
    Clin Exp Metastasis; 2017 Jan; 34(1):93-101. PubMed ID: 27718076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the pre-metastatic niche on breast cancer metastasis.
    Ursini-Siegel J; Siegel PM
    Cancer Lett; 2016 Sep; 380(1):281-8. PubMed ID: 26577808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Press DJ; Miller ME; Liederbach E; Yao K; Huo D
    Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
    Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
    Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.
    Narkhede AA; Shevde LA; Rao SS
    Int J Cancer; 2017 Sep; 141(6):1091-1109. PubMed ID: 28439901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
    Wood SL; Pernemalm M; Crosbie PA; Whetton AD
    Cancer Treat Rev; 2014 May; 40(4):558-66. PubMed ID: 24176790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer: metastatic patterns and their prognosis.
    Patanaphan V; Salazar OM; Risco R
    South Med J; 1988 Sep; 81(9):1109-12. PubMed ID: 3420442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.